Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Gonorrhea Treatment Market size is projected to witness around 3.6% CAGR during the forecast period i.e., between 2025-2037.
The growth of the gonorrhea treatment market can be attributed to the growing prevalence of gonorrhea, increasing incidents of unprotected sex, and rise in implementation of national screening programs. In 2018, more than 1.5 million gonococcal infections occurred in the United States. Among these, more than half of the people were aged between 15-24 years. Along with these, huge investments in the R&D activities to develop effective treatment options is also expected to drive market growth in the near future. Furthermore, improvement in healthcare infrastructure in developed nations and expanding advent of new diagnostic tests are evaluated to offer lucrative opportunities to the market in the coming years.
Gonorrhea Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Gonorrhea Globally
- Growing Implementation of National Screening Programs
Challenges
- Negative Perception About People Visiting STD Clinics
Gonorrhea Treatment Market: Key Insights
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
3.6% |
|
Regional Scope |
|
Gonorrhea Treatment Segmentation
The market is segmented by treatment into monotherapy and dual therapy, out of which, the dual therapy segment is anticipated to hold the largest share in the gonorrhea treatment market on account of increasing preference of this therapy over monotherapy for treating symptomatic and asymptomatic gonorrhea, and the rising adoption of the treatment regime globally. Moreover, as dual therapy with azithromycin and ceftriaxone is considered to be as the first-line regimen for treating gonorrhea, the segment is anticipated to also witness noteworthy growth in the forecast period. Additionally, on the basis of distribution channel, the segment for hospital pharmacies is evaluated to occupy the largest market share during the forecast period. This can be credited to the ease to receive prescribed medicines from the hospital facility itself.
Our in-depth analysis of the global market includes the following segments
|
By Treatment |
|
|
By Infection Type |
|
|
By Distribution Channel
|
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportGonorrhea Treatment Industry - Regional Synopsis
North America Market Statistics
On the basis of geographical analysis, the gonorrhea treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is expected to dominate majority revenue share by 2037, on the back of easy availability of advanced technology and high standards of healthcare infrastructure in the region. In addition, increasing awareness about the disease and promising reimbursement policies are also expected to drive market growth in the region.
APAC Market Analysis
However, the gonorrhea treatment market in Asia Pacific is assessed to witness the highest growth during the forecast period ascribing to the rising prevalence of the disease, rapid change in lifestyles and growing availability of cure for sexually transmitted diseases in the region. In India, more than 5% of the population is affected with a STD. On an average, every year 8-25% men suffer from gonorrhea.
Companies Dominating the Gonorrhea Treatment Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Allergan Inc.
- F. Hoffman-La Roche Ltd
- GlaxoSmithKline plc
- Lupin Pharmaceuticals, Inc.
- Abbott Laboratories
- Siemens AG
- Tosoh Corporation
- PerkinElmer, Inc.
- Johnson & Johnson Services, Inc.
In the News
Author Credits: Radhika Pawar
- Report ID: 3077
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT
